English

English 中文

Core advantage

  • No.1
    World's first
    Vitrification freezing/thawing is fully automated
  • 120
    patent technology
    Has 120 patents (including 19 inventions and 43 PCTs)
  • 300万+
    Annual production capacity
    Annual production of 3 million embryo freezing/thawing consumables
  • 5900㎡
    Medical GMP production site
    5900 square metres of medical GMP production facility

The world's first exclusive product

Automatic glass-crystallising freeze-thaw device

  • High success rate
  • High stability
  • Highly compatible
  • high throughput
The pregnancy rate of cow embryos is close to that of fresh embryos, mouse embryo transfer success and litter rates are better than manual methods, and recovery performance is excellent
Standard automated operations eliminate human errors, ensuring data stability and repeatability
Perfectly compatible with mainstream manual glass freezing and thawing operations, no extra process changes needed, easily upgrading traditional manual operations to automation
4 channels operate independently, supporting uninterrupted cycle loading, greatly improving embryo processing efficiency

Automatic vitrification thawing and embryo loading system

  • Ultra portable
  • Extremely high success rate
  • No need for a microscope or elution
The whole machine weighs just 7.3kg, and with only a bit of training, breeders can carry the suitcase and do tasks in the ranch that used to be done only by embryologists
In the latest 534 cow embryo tests, the tube loading success rate reached an impressive 99.81%.
The device uses micro-actuators to transfer embryos directly from the microwells into a 0.25 mL transfer pipette with precise control of physical force

Application area

About us

Biorocks was founded in 2017 and is a high-tech company specialising in automated cell operation technology. Since its establishment, the company has focused on automating processes in cell biomedicine, livestock, and laboratory animals, aiming to provide fully automated, standardised, and high-throughput solutions for cell screening, cultivation, vitrification freezing, and thawing. Its pioneering technology and core products have reshaped standard lab procedures. The company has applied for and owns 120 core patents, with independently controllable core technologies. It has successfully completed five rounds of investment from well-known institutions and has won numerous awards in top domestic and international science and technology competitions.
Learn more Contact Us

Partner

  • Partner organisation
  • People we serve